Lista de obras -

A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma

artículo científico publicado en 2011

BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells

artículo científico publicado en 2020

Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib

scientific article published on 18 April 2018

Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study

artículo científico publicado en 2020

C14 and C16 acylcarnitines in newborns with orofacial clefts

artículo científico publicado en 2012

Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis

artículo científico publicado en 2020

Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.

artículo científico publicado en 2019

Developing Symptom Lists for People with Cancer Treated with Targeted Therapies

artículo científico publicado en 2020

Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence

artículo científico publicado en 2020

Follow-up in melanoma patients

artículo científico publicado en 2014

Follow-up in soft tissue sarcomas

artículo científico publicado en 2014

Functional outcome of surgical treatment of adults with extremity osteosarcoma after megaprosthetic reconstruction-single-center experience.

artículo científico publicado en 2019

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications

artículo científico publicado en 2014

Genetic polymorphisms may influence the vertical growth rate of melanoma

article published in 2018

Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization f

artículo científico publicado en 2015

High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors

artículo científico publicado en 2018

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

artículo científico publicado en 2017

IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma.

artículo científico publicado en 2018

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study.

artículo científico publicado en 2019

Immunotherapy of melanoma

artículo científico publicado en 2018

Long-term follow-up in adults with extremity osteosarcoma: comparison of different surgical procedures - single-center experience

artículo científico publicado en 2019

Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma

artículo científico publicado en 2017

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

artículo científico publicado en 2020

Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma

artículo científico publicado en 2018

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy

artículo científico publicado en 2020

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor.

artículo científico publicado en 2019

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors

scientific article published on 30 August 2019

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure

scientific article published on 16 July 2019

Serum markers in early-stage and locally advanced melanoma

artículo científico publicado en 2015

The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma

artículo científico publicado en 2020

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).

artículo científico publicado en 2017

The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcoma

artículo científico publicado en 2020

The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults

artículo científico publicado en 2016

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

artículo científico publicado en 2012

The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma

scientific article published on 17 February 2020

Trametinib: a MEK inhibitor for management of metastatic melanoma

artículo científico publicado en 2015

Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice

scientific article published on 01 December 2019

Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST).

artículo científico publicado en 2018

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer

artículo científico publicado en 2019

Whole blood citrulline concentrations in newborns with non-syndromic oral clefts--a preliminary report.

artículo científico publicado en 2010

Whole blood propionylcarnitine in newborns with orofacial cleft

artículo científico publicado en 2011

[Extracellular domain of HER-2 as a prognostic factor in osteosarcoma. A pilot study]

artículo científico publicado en 2009

[The prognostic role of clinical factors, VEGF, IL-8 and sTNF-R1 in cutaneous melanomas at locoregional stage]

scientific article published on 01 January 2012

Lista de obras de

A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma

BRAF inhibition curtails IFN-gamma-inducible PD-L1 expression and upregulates the immunoregulatory protein galectin-1 in melanoma cells

Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib

Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study

C14 and C16 acylcarnitines in newborns with orofacial clefts

Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis

Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage.

Developing Symptom Lists for People with Cancer Treated with Targeted Therapies

Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients - Real world evidence

Follow-up in melanoma patients

Follow-up in soft tissue sarcomas

Functional outcome of surgical treatment of adults with extremity osteosarcoma after megaprosthetic reconstruction-single-center experience.

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications

Genetic polymorphisms may influence the vertical growth rate of melanoma

Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization f

High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma.

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study.

Immunotherapy of melanoma

Long-term follow-up in adults with extremity osteosarcoma: comparison of different surgical procedures - single-center experience

Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy

Plasma lncRNA expression profile as a prognostic tool in BRAF-mutant metastatic melanoma patients treated with BRAF inhibitor.

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure

Serum markers in early-stage and locally advanced melanoma

The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).

The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcoma

The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma

Trametinib: a MEK inhibitor for management of metastatic melanoma

Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice

Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST).

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer

Whole blood citrulline concentrations in newborns with non-syndromic oral clefts--a preliminary report.

Whole blood propionylcarnitine in newborns with orofacial cleft

[Extracellular domain of HER-2 as a prognostic factor in osteosarcoma. A pilot study]

[The prognostic role of clinical factors, VEGF, IL-8 and sTNF-R1 in cutaneous melanomas at locoregional stage]